Scpharmaceuticals Drug Patent Portfolio
Scpharmaceuticals owns 1 orange book drug protected by 4 US patents Given below is the list of Scpharmaceuticals's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10272064 | Pharmaceutical formulations for subcutaneous administration of furosemide | 03 Apr, 2034 | Active |
| US11433044 | Pharmaceutical formulations for subcutaneous administration of furosemide | 03 Apr, 2034 | Active |
| US12370168 | 03 Apr, 2034 | Active | |
| US9884039 | Pharmaceutical formulations for subcutaneous administration of furosemide | 03 Apr, 2034 | Active |
Latest Legal Activities on Scpharmaceuticals's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Scpharmaceuticals.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 21 Jan, 2023 | US9884039 |
| Mail Certificate of Correction Memo | 20 Jan, 2023 | US9884039 |
| Certificate of Correction Memo | 18 Jan, 2023 | US9884039 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 31 Oct, 2022 | US10272064 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 06 Sep, 2022 | US11433044 |
|
Recordation of Patent Grant Mailed
Critical
| 06 Sep, 2022 | US11433044 |
|
Email Notification
Critical
| 18 Aug, 2022 | US11433044 |
|
Issue Notification Mailed
Critical
| 17 Aug, 2022 | US11433044 |
| Dispatch to FDC | 28 Jul, 2022 | US11433044 |
|
Application Is Considered Ready for Issue
Critical
| 28 Jul, 2022 | US11433044 |
|
Issue Fee Payment Received
Critical
| 26 Jul, 2022 | US11433044 |
|
Issue Fee Payment Verified
Critical
| 26 Jul, 2022 | US11433044 |
|
Electronic Review
Critical
| 28 Apr, 2022 | US11433044 |
|
Mail Notice of Allowance
Critical
| 28 Apr, 2022 | US11433044 |
|
Email Notification
Critical
| 28 Apr, 2022 | US11433044 |
Scpharmaceuticals's Family Patents
Scpharmaceuticals Drug List
Given below is the complete list of Scpharmaceuticals's drugs and the patents protecting them.
1. Furoscix
Furoscix is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10272064 | Pharmaceutical formulations for subcutaneous administration of furosemide |
03 Apr, 2034
(8 years from now)
| Active |
| US11433044 | Pharmaceutical formulations for subcutaneous administration of furosemide |
03 Apr, 2034
(8 years from now)
| Active |
| US12370168 |
03 Apr, 2034
(8 years from now)
| Active | |
| US9884039 | Pharmaceutical formulations for subcutaneous administration of furosemide |
03 Apr, 2034
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Furoscix's drug page